Key Takeaways Heavy dependence on government partnerships makes Krsnaa vulnerable to policy changes, payment delays, and margin pressures despite recurring revenue streams. Intensifying competition, regulatory headwinds, and rapid expansion risks could limit profitability and returns, even as demand and digital adoption in diagnostics rise.Read more
Key Takeaways Aggressive PPP and retail expansion, combined with tech-enabled cost advantages, position the company for structurally higher margins and outsized long-term earnings growth. First-mover status and deep hospital partnerships enable strong cross-selling, market share gains, and potential for continued industry-leading revenue and margin expansion.Read more
Key Takeaways Geographic and retail expansion, supported by public-private partnerships and digital initiatives, is expected to drive revenue growth and improve margins. Increased healthcare demand and efficient collections are enhancing cash flow quality and strengthening long-term operational performance.Read more
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
